Association Between Immune-Related Adverse Events and Survival in Patients with Hepatocellular Carcinoma Treated With Atezolizumab Plus BevacizumabTaito Fukushima, Shin Maeda, Haruki Uojima et al.|The Oncologist|2023Cited by 42
Impact of body composition for patients with hepatocellular carcinoma who received atezolizumab plus bevacizumab therapyHaruki Uojima, Chika Kusano, Makoto Chuma et al.|European Journal of Gastroenterology & Hepatology|2023Cited by 9